Mitochondrial function in heart and kidney of spontaneously hypertensive rats: Influence of captopril treatment

General Physiology and Biophysics

Volumn 29, Issue 2, 2010, Pages 203-207

  Mujkošová, Jana ^a   Uličná, Ol'ga ^b   Waczulíková, Iveta ^c   Vlkovičová, Jana ^a   Vančová, Ol'ga ^b   Ferko, Miroslav ^a   Polák, Štefan ^b   Ziegelhöffer, Attila ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^c Physics and Informatics   (Slovakia)

Author keywords

Captopril; Heart; Kidney; Mitochondria; Spontaneous hypertensive rats

Indexed keywords

ADENOSINE TRIPHOSPHATASE (MAGNESIUM); ADENOSINE TRIPHOSPHATE; CAPTOPRIL; GLUTAMIC ACID; MALIC ACID; ADENOSINE TRIPHOSPHATASE (CALCIUM MAGNESIUM); ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MITOCHONDRION; HYPERTENSION; KIDNEY; MEMBRANE FLUIDITY; MITOCHONDRION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; ENERGY METABOLISM; METABOLISM; WISTAR RAT;

RATTUS;

ADENOSINE TRIPHOSPHATE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; CA(2+) MG(2+)-ATPASE; CAPTOPRIL; ENERGY METABOLISM; HYPERTENSION; KIDNEY; MITOCHONDRIA; MITOCHONDRIA, HEART; RATS; RATS, INBRED SHR; RATS, WISTAR;

EID: 77954121202     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: 10.4149/gpb_2010_02_203     Document Type: Article

References (14)

1. De Cavanagh E. M., Piotrkowski B., Basso N., Stella I., Inserra F., Ferder L., Fraga C.G. (2003): Enalapril and losartan attenuate mitochondrial dysfunction in aged rats. FASEB J. 17, 1096-1098
2. Ferko M., Gvozdjaková A., Kucharská J., Mujkošová J., Waczulíková I., Styk J., Ravingerová T., Ziegelhöffer-Mihalovičová B., Ziegelhöffer A. (2006): Functional remodeling of heart mitochondria in acute diabetes: interrelationships between damage, endogenous protection and adaptation. Gen. Physiol. Biophys. 25, 397-413
3. Ferko M., Habodászová D., Waczulíková I., Mujkošová J., Kucharská J., Šikurová L., Ziegelhöffer B., Styk J., Ziegelhöffer A. (2008): Endogenous protective mechanisms in remodeling of rat heart mitochondrial membranes in the acute phase of streptozotocin-induced diabetes. Physiol. Res. 57, (Suppl. 2), S67-73
4. Kuneš J., Zicha J. (2006): Developmental windows and environment as important factors in the expression of genetic information: a cardiovascular physiologist's view. Clinical Science 111, 295-305; doi:10.1042/CS20050271
5. Lowry O. H., Rosenbrough N. J., Farr A., L., Randall R. J. (1953): Protein measurement with the pholin phenol reagent. J. Biol. Chem. 193, 265-275
6. Máleková L., Komínková V., Ferko M., Štefánik P., Križanová O., Ziegelhöffer A., Szewczyk A., Ondriáš K. (2007): Bongkrekic acid and atractyloside inhibits chloride channels in mitochondrial membranes of rat heart. Biochim. Biophys. Acta 1767, 31-44; doi:10.1016/j.bbabio.2006.10.004
7. 2+-ATPase activity, content of conjugated dienes and membrane fluidity. Physiol. Res. 57, (Suppl. 2), S75-82
8. Postnov Y. V., Orlov S. N., Budnikov Y. Y., Doroschuk A. D., Postov A. Y. (2007): Mitochondrial energy conversion disturbance with decrease in ATP production as a source of systemic arterial hypertension. Pathopysiology 14, 195-204; doi:10.1016/j.pathophys.2007.09.002
9. Roman M. J., Saba P. S., Pini R., Spitzer M., Pickering T. G., Rosen S., Alderman M. H., Devereux R. B. (1992): Parallel cardiac and vascular adaptation in hypertension. Circulation 86, 1909-1918
10. Rydén L., Waeber B., Ruilope L. M., Mancia G., Volpe M., Holzgreve H., Mogensen C. E., Leurent S. (2009): The management of the type 2 diabetic patient with hypertension too late and too little: suggested improvements. Blood press. 17, 250-259; doi:10.1080/08037050802513387
11. Seppet E., Gizatullina Z., Trumbeckaite S., Ziery S., Striggow S., Gellerich F. N. (2007): Mitochondrial medicine: the central role of cellular energetic depression and mitochondria in cell pathophysiology. In: Molecular System Bioenergetics: Energy for Life (Ed. V. Saks), pp. 479-520, WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
12. Šimko F., Pecháňová O. (2009): Recent trends in hypertension treatment: perspectives from animal studies. J. Hypertens. 27, (Suppl. 6), S1-10; doi:10.1097/01.hjh.0000358829.87815.d4
13. Waczulíková I., Habodászová D., Cagalínec M., Ferko M., Uličná O., Mateašík A. Šikurová L., Ziegelhöffer A. (2007): Mitochondrial membrane fluidity, potential and caldum transients in the myocardium from acute diabetic rats. Can. J. Physiol. Pharmacol. 85, 372-384; doi:10.1139/Y07-035
14. Ziegelhöffer A., Waczulíková I., Ferko M., Kincelová D., Ziegelhöffer B., Ravingerová T., Cagalínec M., Schönburg M., Ziegelhöffer T., Šikurová L., Uličná O., Mujkošová J. (2009): Calcium signaling-mediated endogenous protection of cell energetics in the acutely diabetic myocardium. Can. J. Physiol. Pharmacol. 87, 1083-1094; doi:10.1139/Y09-108